Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, United Kingdom
Ephedrine tablets are indicated for the treatment or prevention of attacks of bronchospasm in asthma.
15–60mg three times daily.
under 1 year: not recommended.
1–5 years: 15mg three times daily.
6–12 years: 30mg three times daily.
Dosage should be substantially reduced. Initial therapy should be 50% of adult dose.
The symptoms of overdose are normally seen as nausea, vomiting, hypertension, fever, palpitations, tachycardia, restlessness, respiratory depression and convulsions. Paranoid psychosis, delusions and hallucinations may also follow ephedrine overdosage.
In severe overdosage, the stomach should be emptied by emesis and lavage. Management is by supportive symptomatic therapy.
Polypropylene and polyethylene containers: Three years.
Blister strips: Two years.
Do not store above 25°C.
Store in the original container in order to protect from light.
Polypropylene or polyethylene containers with tamper evident closure. Each pack contains 28, 30, 56, 60, 84, 90, 100, 250 or 1000 tablets.
Blister strips of 28, 30, 56, 60, 84, 90 tablets.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
